Concepedia

Katy O. Goyak

KO

Statistics

Publications

10

Citations

262

H-Index

10

Active since

2008

Affiliations

ExxonMobil (United States)(Current)

American Chemistry Council

Dow Chemical (United States)

American Petroleum Institute

DuPont (United States)

Katy O. Goyak is an author at ExxonMobil (United States) specializing in pharmacy, toxicology, and chemical hazard assessment.

Publications per year

2008–2023

10

Publications

10

Hepatocyte Differentiation

Katy O. Goyak, Elizabeth M. Laurenzana, Curtis J. Omiecinski · Methods in molecular biology · 2010 · 54 citations

Medicine, Cell Biology, Toxicology +15

Use and validation of HT/HC assays to support 21st century toxicity evaluations

Grace Patlewicz, Ted W. Simon, Katy O. Goyak et al. · Regulatory Toxicology and Pharmacology · 2013 · 41 citations · Full text

Pharmacy, Bioinformatics, Toxicology +15

Expression profiling of interindividual variability following xenobiotic exposures in primary human hepatocyte cultures

Katy O. Goyak, Mary C. Johnson, Stephen C. Strom et al. · Toxicology and Applied Pharmacology · 2008 · 39 citations

Pharmacy, Biochemistry, Molecular Biology +17

Developing scientific confidence in HTS-derived prediction models: Lessons learned from an endocrine case study

Louis Anthony Cox, Douglas A. Popken, M. Sue Marty et al. · Regulatory Toxicology and Pharmacology · 2014 · 30 citations · Full text

Medicine, Endocrinology, Toxicology +8

Acute, Subchronic, and Developmental Toxicological Properties of Lubricating Oil Base Stocks

Walden E. Dalbey, Richard H. McKee, Katy O. Goyak et al. · International Journal of Toxicology · 2014 · 26 citations

Pharmacy, Chemical Engineering, Toxicology +15

1–5 of 10